Cited by 279Nitric Oxide and Endothelin EffectsRedox biology and oxidative stressHemoglobin structure and function

Nitroxyl (HNO): the Cinderella of the nitric oxide story

Irvine, Jennifer C., Ritchie, Rebecca H., Favaloro, Joanne L., Andrews, Karen L., Widdop, Robert E., Kemp-Harper, Barbara K.·2008·Trends in Pharmacological Sciences

Abstract

Until recently, most of the biological effects of nitric oxide (NO) have been attributed to its uncharged state (NO*), yet NO can also exist in the reduced state as nitroxyl (HNO or NO(-)). Putatively generated from both NO synthase (NOS)-dependent and -independent sources, HNO is rapidly emerging as a novel entity with distinct pharmacology and therapeutic advantages over its redox sibling, NO*. Thus, unlike NO*, HNO can target cardiac sarcoplasmic ryanodine receptors to increase myocardial contractility, can interact directly with thiols and is resistant to both scavenging by superoxide (*O2-) and tolerance development. HNO donors are protective in the setting of heart failure in which NO donors have minimal impact. Here, we discuss the unique pharmacology of HNO versus NO* and highlight the therapeutic potential of HNO donors in the treatment of cardiovascular disease.

Integrity signals

Registry

Crossref · 10.1016/j.tips.2008.08.005

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Kemp-Harper et al. suggested that HNO mediates dilation through activation of Kca and Kv channels in vascular smooth muscle.

    “Kemp-Harper et al. have suggested that HNO is a mediator of dilation through activation of Kca and Kv channels in vascular smooth muscle [196, 197].”

    From Signaling and stress: The redox landscape in NOS2 biology (2015) · cites this paper as [196]

Cites

Flagged first, then by citations

1 of the 64 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Irvine, J. C., Ritchie, R. H., Favaloro, J. L., Andrews, K. L., Widdop, R. E., & Kemp-Harper, B. K.
Affiliations
  • Baker Heart and Diabetes Institute (AU)
  • RMIT University (AU)
  • Monash University (AU)
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2008-12
Volume
29
Issue
12
Pages
601-608
ISSN
0165-6147 (ISSN-L)
OpenAlex
W2043286086
Cited by
277
References
64
Citations by year
2026: 3 · 2025: 12 · 2024: 15 · 2023: 8 · 2022: 13 · 2021: 11 · 2020: 11 · 2019: 13 · 2018: 8 · 2017: 19 · 2016: 25 · 2015: 22 · 2014: 16 · 2013: 19 · 2012: 26
FWCI
2.02
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Pharmacological Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • RMIT Research Repository (RMIT University Library) (submittedVersion)
  • Figshare (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hemoglobin structure and function
Keywords
nitroxyl, nitric oxide, nitric oxide donors, nitric oxide synthase, cardiac contractility, superoxide radical scavenging, heart failure, cardiovascular disease treatment
MeSH terms
Alcoholism, Animals, Antioxidants, Cardiovascular Diseases, Humans, Nitric Oxide, Nitrogen Oxides, Nitric Oxide Donors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review